These data suggest that IL4 signaling can be a master regulator that controls multiple downstream effectors in MAMs that have been shown by genetic ablation or antibody inhibition to be important during tumor cell metastatic seeding (CCL2, CCR1) and growth (FLT1, CSF1) in vivo (Figure 5F). This evidence concerns the gene IL4 and neoplasm.